CSI Market
Sign In | Register

Aeon Biopharma inc (AEON) Annual Balance Sheets

Annual · GAAP · USD millions
Access AEON quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Aeon Biopharma inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/AEON/balance-sheets
https://api.csimarket.com/api/v1/companies/AEON/fundamentals
https://api.csimarket.com/api/v1/companies/AEON/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent3.01
Cash & Short-term Investments3.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.39
Total Current Assets3.40
Equipment/Property/Plant Net0.16
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent2.00
Operating Lease Right Of Use Asset1.05
Total Assets5.56
Liabilities
Accounts Payable, Current AC0.94
Employee-related Liabilities, Current AC2.87
Other Liabilities, Current3.08
Sales and Excise Tax Payable, Current0.00
Total Current Liabilities6.90
Convertible Notes Payable, Noncurrent LO34.60
Total Long-term Debt34.60
Derivative Liability, Noncurrent DE14.88
Other liabilities, Noncurrent4.21
DeferredUnderwritingCompensationsNoncurrent-
Accrued Clinical Trails Expenses Current1.43
Operating Lease Liability Noncurrent0.89
Total Liabilities60.59
Stockholders' Equity
Subscription Receivables-
Common Stock Value0.01
Additional Paid In Capital Common Stock415.78
Retained Earnings / Accumulated Deficit-470.82
Defined Benefit Plan and Other3.28
Other Equity-3.28
Common Stockholder's Equity-55.03
Non-controlling interests & other0.00
Total Stockholder's Equity-55.03
Liabilities & Stockholder's Equity5.56
4 historic quarters locked

Sign in to unlock the full Aeon Biopharma inc balance sheet history.

Sign In Create Free Account

About Aeon Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001837607-26-000019

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI